Evaluation of four commercially available enzyme immunoassays for laboratory diagnosis of Clostridium difficile-associated diseases.

Four commercial enzyme immunoassays (EIAs) for the detection of Clostridium difficile toxin A have recently been developed and marketed (Premier, Meridian Diagnostics, Cincinnati, Ohio; VIDAS, bioMerierux Vitek, Inc., Hazelwood, Mo.; Tox-A-Test, TechLab, Blacksburg, Va.; and Bartels, Baxter Diagnost...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	J Clin Microbiol
Hauptverfasser:	Whittier, S, Shapiro, D S, Kelly, W F, Walden, T P, Wait, K J, McMillon, L T, Gilligan, P H
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1993
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC266145/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8263168/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jcm.31.11.2861-2865.1993
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!